Inducing lung immune centers
Nature Immunology
June 13, 2011
Clues as to how inducible immune tissues arise in the lung are found in a report published online this week in Nature Immunology.
Patients with chronic obstructive pulmonary disease commonly exhibit clusters of immune cells that are collectively known as iBALT. Such clusters promote rapid immune responses to inhaled allergens or particles, such as soot or cigarette smoke, and can perpetuate chronic lung inflammation and lead to tissue damage.
Troy Randall and colleagues show that neonatal mice are exquisitely prone to development of iBALT structures upon exposure to inflammatory stimuli. They find that the signaling molecule IL-17 is essential to this process as it induces upregulation of specific chemoattractant molecules that leads to iBALT formation. These iBALT then persist for months via an IL-17-independent process involving another immune signaling molecule called lymphotoxin.
Strategies to block IL-17 and lymphotoxin might prove useful in therapeutics for chronic obstructive pulmonary disease or autoimmune diseases, such as Sjogren’s syndrome, that are associated aberrant formation of lymphoid tissues.
doi: 10.1038/ni.2053
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature